The Fearless Science Speaker Series features Morgridge Institute for Research scientists and collaborators discussing innovative biomedical research.
The Morgridge Institute for Research is an independent biomedical institute. Our scientists recognize that a fundamental understanding of human biology will drive the next big advances in human health. We conduct “fearless science” in these promising frontiers.
Upcoming EventsSee all upcoming events »
Morgridge biomedical imaging investigator Dr. Melissa Skala and University of Wisconsin–Madison medical oncologist Dr. Mark Burkard discuss the future of cancer care in the latest Fearless Science Speaker Series webinar.
What is the future outlook of the COVID-19 pandemic? Experts discussed where we are and the path forward on February 17, 2022 in a Fearless Science Speaker Series webinar.
Over 18 months into the COVID-19 pandemic, and vaccines are now available for children 5-11. Experts on the front lines of pediatric vaccine development and public health addressed questions during a Fearless Science Speaker Series webinar on November 9, 2021.
Multiple COVID-19 vaccines are available, but some people are on the fence about getting their shot. Approaching a conversation with vaccine-hesitant friends and family may be challenging. Three scientists and public health experts spoke to more than 250 members during a Fearless Science Seminar Series.
Johan den Boon, anesthesiologist Dr. Bill Hartman, and pediatric infectious disease specialist Dr. James Conway presented for a webinar about the science of vaccines.
Morgridge bioethicist in residence Pilar Ossorio, Jonathan Kimmelman, and Seema Shah joined Gabriella Gerhardt on October 27 to discuss the complex ethical questions surrounding a coronavirus vaccine.
Morgridge scientists John Brubacher, Anthony Gitter, Brian Bockelman, Ben Cox and Katie Overmyer, joined Gabriella Gerhardt on July 22 for a Fearless Science webinar about rapidly applying technology and methods to answer COVID-19 questions.
In light of the COVID-19 pandemic, Paul Ahlquist and Tony Gitter joined CEO Brad Schwartz in a webinar where they discussed COVID-19 and the broader context of viral pandemics and how we respond to them.